Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Concord Medical Cancer Center (SCMCC) is a high-end tertiary cancer hospital located in the Shanghai New Hongqiao International Medical Center. Established through a strategic partnership with the MD Anderson Cancer Center, the facility provides comprehensive oncology services including diagnostic imaging, chemotherapy, and advanced radiotherapy. The center is particularly noted for its focus on precision medicine and its integration of international clinical standards into the Chinese healthcare market. It serves as a flagship facility for its parent company, Concord Medical Services, aiming to deliver multidisciplinary cancer care and advanced treatment modalities such as proton therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Concord Medical Cancer Center.